Your Input: | |||||
SMPD3 | Sphingomyelin phosphodiesterase 3. (664 aa) | ||||
BNC2 | Basonuclin 2. (870 aa) | ||||
ARX | Aristaless related homeobox. (539 aa) | ||||
STC1 | Stanniocalcin 1. (247 aa) | ||||
WNT2 | Protein Wnt; Ligand for members of the frizzled family of seven transmembrane receptors; Belongs to the Wnt family. (357 aa) | ||||
FGF8 | Fibroblast growth factor; Belongs to the heparin-binding growth factors family. (228 aa) | ||||
TGFB2 | Transforming growth factor beta; Belongs to the TGF-beta family. (413 aa) | ||||
GATA6 | GATA binding protein 6. (514 aa) | ||||
FGF7 | Fibroblast growth factor; Belongs to the heparin-binding growth factors family. (194 aa) | ||||
LEPR | Leptin receptor. (1150 aa) | ||||
ANXA6 | Annexin. (664 aa) | ||||
DLL1 | Delta-like protein; Putative Notch ligand involved in the mediation of Notch signaling. (726 aa) | ||||
IFT80 | Intraflagellar transport 80. (778 aa) | ||||
AR | Androgen receptor. (721 aa) | ||||
CER1 | Cerberus 1, DAN family BMP antagonist. (275 aa) | ||||
MAP2K4 | Mitogen-activated protein kinase kinase 4. (328 aa) | ||||
HLX | H2.0 like homeobox. (354 aa) | ||||
LOC102450523 | Uncharacterized protein. (181 aa) | ||||
FXN | Frataxin. (159 aa) | ||||
RARB | Retinoic acid receptor beta. (448 aa) | ||||
NPPC | Uncharacterized protein. (132 aa) | ||||
GJE1 | Gap junction protein epsilon 1. (205 aa) | ||||
JARID2 | Jumonji and AT-rich interaction domain containing 2. (1232 aa) | ||||
PDLIM5 | PDZ and LIM domain 5. (603 aa) | ||||
ARID2 | AT-rich interaction domain 2. (1824 aa) | ||||
K7FGP4_PELSI | TSP C-terminal domain-containing protein. (950 aa) | ||||
TMEM38B | Transmembrane protein 38B. (279 aa) | ||||
TGFBR2 | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] (584 aa) | ||||
OSTN | Osteocrin. (134 aa) | ||||
NKX2-5 | NK2 homeobox 5. (272 aa) | ||||
AKAP13 | A-kinase anchoring protein 13. (2319 aa) | ||||
DDR2 | Discoidin domain receptor tyrosine kinase 2. (887 aa) | ||||
MMP13 | Matrix metallopeptidase 13. (472 aa) | ||||
ADRA1A | Adrenoceptor alpha 1A. (467 aa) | ||||
DIPK2A | Divergent protein kinase domain 2A. (297 aa) | ||||
UBE3A | Ubiquitin-protein ligase E3A; E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and transfers it to its substrates. (882 aa) | ||||
EVC | EvC ciliary complex subunit 1. (952 aa) | ||||
SAV1 | Salvador family WW domain containing protein 1. (313 aa) | ||||
LOC102458614 | Uncharacterized protein. (824 aa) | ||||
SMAD1 | Mothers against decapentaplegic homolog. (427 aa) | ||||
ESR1 | Estrogen receptor; The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. (588 aa) | ||||
IL7 | Uncharacterized protein. (144 aa) | ||||
TENM4 | Teneurin transmembrane protein 4. (2608 aa) | ||||
WNT2B | Protein Wnt; Ligand for members of the frizzled family of seven transmembrane receptors; Belongs to the Wnt family. (334 aa) | ||||
LOC102457599 | TGF-beta receptor type-2; Transmembrane serine/threonine kinase forming with the TGF- beta type I serine/threonine kinase receptor, TGFBR1, the non- promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinoge [...] (567 aa) | ||||
BCL2 | BCL2 apoptosis regulator. (232 aa) | ||||
K7F553_PELSI | NR LBD domain-containing protein. (123 aa) | ||||
RARA | Retinoic acid receptor alpha. (343 aa) | ||||
RAG2 | Recombination activating 2. (533 aa) |